$28.2728.27 -0.66-0.66 |(-2.28-2.28 %)
52W H: 35.8352W L: 17Beta: 1.42
About ArriVent BioPharma Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://arrivent.com/
Frequently Asked Questions
What is the 52-week range for AVBP?
The 52-week high is $35.83 and the 52-week low is $17.
What is the P/E ratio for AVBP?
The P/E ratio data is currently unavailable.
What is the dividend yield for AVBP?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -50.26%.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 2.70.
Analyst Recommendation Trends
Wall Street analyst consensus for AVBP over the last few months:
2026-09-01
Buy: 10
S.Buy: 7
Hold: 1
Sell: 0
2026-08-01
Buy: 10
S.Buy: 7
Hold: 1
Sell: 0
2026-07-01
Buy: 11
S.Buy: 7
Hold: 1
Sell: 0
2026-06-01
Buy: 11
S.Buy: 7
Hold: 1
Sell: 0
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-06-18 | Parsey Merdad | +13,562 | - | - |
| 2026-06-18 | Nolet Chris | +13,562 | - | - |
| 2026-06-18 | Hohneker John | +13,562 | - | - |
| 2026-06-18 | Peterson Kristine | +13,562 | - | - |
| 2026-02-02 | LaChapelle Robin | +130,000 | - | - |
| 2026-02-02 | Lutzker Stuart | +150,000 | - | - |
| 2026-02-02 | Kastenmayer James Paul | +130,000 | - | - |
| 2026-02-02 | Kung Winston | +140,000 | - | - |
| 2026-02-02 | Yao Zhengbin | +550,000 | - | - |
| 2025-12-10 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | -555,555 | $23.37 | $12,983,320 |